These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17272871)

  • 21. Biological options to enhance periprosthetic bone mass.
    Tsiridis E; Gamie Z; Conaghan PG; Giannoudis PV
    Injury; 2007 Jun; 38(6):704-13. PubMed ID: 17477926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How menopause affects oral health, and what we can do about it.
    Buencamino MC; Palomo L; Thacker HL
    Cleve Clin J Med; 2009 Aug; 76(8):467-75. PubMed ID: 19652040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H
    Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E; Wutoh AK; Xue Z; Hillman JJ; Zuckerman IH
    J Womens Health (Larchmt); 2006 Mar; 15(2):155-61. PubMed ID: 16536679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis.
    Kung AW; Chu EY; Xu L
    Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestrogen and selective oestrogen receptor modulators (SERMs): current roles in the prevention and treatment of osteoporosis.
    Albertazzi P; Purdie DW
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):451-68. PubMed ID: 11485340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral implications of osteoporosis.
    Dervis E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Sep; 100(3):349-56. PubMed ID: 16122665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatase inhibitors and bone health.
    Bundred NJ
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):60-7. PubMed ID: 19125005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 30. [Right or wrong of the hormone replacement therapy involving osteoporosis].
    Hoshino S; Ouchi Y
    Clin Calcium; 2004 Nov; 14(11):87-98. PubMed ID: 15577164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy for treatment of osteoporosis: A review.
    Pinkerton JV; Dalkin AC
    Am J Obstet Gynecol; 2007 Dec; 197(6):559-65. PubMed ID: 18060937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis and osteopenia: implications for periodontal and implant therapy.
    Otomo-Corgel J
    Periodontol 2000; 2012 Jun; 59(1):111-39. PubMed ID: 22507063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for the management of postmenopausal osteoporosis for GPs.
    O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF;
    Aust Fam Physician; 2004 Nov; 33(11):910-9. PubMed ID: 15584331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to manage osteoporosis after the menopause.
    Compston J
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1007-19. PubMed ID: 16301194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lasofoxifene for postmenopausal women with osteoporosis.
    Malozowski S
    N Engl J Med; 2010 Jun; 362(23):2227; author reply 2228-9. PubMed ID: 20558377
    [No Abstract]   [Full Text] [Related]  

  • 37. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in bisphosphonate therapy.
    Silverman SL; Maricic M
    Semin Arthritis Rheum; 2007 Aug; 37(1):1-12. PubMed ID: 17303219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment and prevention of osteoporosis in patients with decreased renal function].
    Vestergaard P; Eiken PA
    Ugeskr Laeger; 2008 Jan; 170(4):227-30. PubMed ID: 18282452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and pharmacologic therapy of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Jul; 144(28):1373-9. PubMed ID: 12914121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.